Latest News
-
NEW STUDY: speech and language in individuals with SYNGAP1-DEE
Our Speech & Language team is launching an international research study examining speech and language outcomes in individuals with SYNGAP1-developmental and epileptic encephalopathy.
Hear Ms Alecka Garrett, PhD candidate and speech pathologist, discuss the study in this informative reel.
-
Childhood Apraxia of Speech Trial
We are trialling a new treatment for children with childhood apraxia of speech (CAS). This treatment is the drug methylphenidate (MPH), commonly known as Ritalin. We want to find out whether MPH can help improve the speech and language symptoms of CAS in children aged 6-12 years.Hear Ms Lorraine O'Donnell, Registered Nurse and Coordinator of this trial, explain our study in this informative reel. -
Dr Miya St John awarded a Harold Mitchell Foundation Travelling Fellowship
Dr Miya St John was awarded a Harold Mitchell Foundation Travelling Fellowship for her contribution to speech research.
The funding enables showcasing her research internationally & strengthen global collaborations.
Miya will use these funds to present at the International Koolen-de Vries Summit next July and learn a long-established therapy for Childhood Apraxia of Speech with our American colleagues.
-
Celebrating Speech Pathology Week - Communicate Your Way
We’re proud to have supported over 250 families, helping them find their unique voices and communicate in their own way. This week, we’re sharing exciting content on our Instagram and Facebook pages. Follow along so you don’t miss out!
-
Centre of Research Excellence (CRE) Symposium 7 June 2024
The Centre of Research Excellence - Translational Centre for Speech Disorders is delighted to co-host their Symposium ‘What’s new since FOXP2: new developments in speech and language neurobiology' together with University College London (UCL) Great Ormond Street Institute of Child Health.
-
Interested in studying a PhD examining speech and language phenotypes of Ataxia Telangiectasia (A-T) in children?
We currently have an exciting PhD opportunity to examine Speech and Language phenotypes at the Ataxia Telangiectasia (A-T) clinic at the Queensland Children’s Hospital which is led by Prof. David Coman.
For more information, please click here.
-
Gene linked to persistent stuttering into adulthood uncovered
A new study led by University of Melbourne researchers has discovered a link between a new gene pathway and structural brain anomalies in some people who stutter into adulthood, opening up promising research avenues to enhance the understanding of persistent developmental stuttering.
-
-
Symposium - Child speech disorders: translating cutting-edge science into clinical practice
The Centre of Research Excellence - Translational Centre for Speech Disorders is delighted to host their first Symposium on Monday 9 October 2023.
-
New funding awarded for Centre of Research Excellence – Translational Centre for Speech Disorders
The Speech and Language Team recently launched a Translational Centre for Speech Disorders following NHMRC Centre of Research Excellence funding awarded for a 5-year period. National and international experts will collaborate to study the neurobiology of speech disorders to better understand the cause of speech disorders such as apraxia of speech. Findings from this research will help transform diagnosis and prognosis and enable precision therapies to improve long term outcomes for children with speech disorders.
For information on Prof Angela Morgan’s insights about this Translational Centre for Speech Disorders, please click here.
-
Interested in studying a PhD on the neuropsychological profile of children with childhood apraxia of speech?
We currently have a PhD opportunity. Applications close December 11th 2022. For more information, please click here or email emma.baker@mcri.edu.au.
-
New genes linked to childhood apraxia of speech
Just published! We have recently published a number of genes newly associated with childhood apraxia of speech/severe speech disorder. These findings further our understanding of the heterogeneity of genetic contributions to the condition. For more information about the publication, please click here.
-
MCRI and Josh Earl
We have been fortunate enough to welcome a collaboration with the Melbourne based comedian Josh Earl. Josh is well known for his work in stand up, radio and television. He openly talks about his speech difficulties as a child in his stand-up routine. Josh will be working with our team to advocate for individuals with speech disorder. To learn more about Josh and his collaboration with MCRI, please click here. To learn more about Josh, please visit www.joshearl.com.au.
-
Genetics of Stuttering Launch
Recruitment for the Genetics of Stuttering study is well underway. Thank you to the 800+ individuals who have already participated! This has been a fantastic response, and participants have been true partners in helping us further refine our survey.
-
We are still recruiting!
We are currently still recruiting for the Genetics of Speech and Genetics of Stuttering studies. If you are interested, or know someone that may be interested please do not hesitate to contact us at (03) 9936 6334 or geneticsofstuttering@mcri.edu.au
Proudly in partnership with
